Metabolism and urinary disposition of N,N‐dimethyltryptamine after oral and smoked administration: a comparative study
Jordi Riba, Ethan H. Mcilhenny, José Carlos Bouso, Steven A. Barker
Drug Testing and Analysis July 28, 2014 DOI: 10.1002/dta.1685 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Observational cohort Peer reviewed |
|---|---|
| Sample size | 6 |
| Population | DMT users |
| Intervention | DMT |
| Dose | 25 mg |
| Topics | 5-MeO-DMT DMT |
| Keywords | Oral administration Urine Ingestion Pharmacology Metabolite Alkaloid Metabolism Pharmacokinetics Hallucinogen |
| Citations | 96 |
| Key findings | Oral DMT is completely metabolized by MAO to indole-3-acetic acid and produces no psychoactive effects, whereas smoked DMT shifts metabolism to CYP-dependent pathways, yielding unmetabolized DMT and psychoactivity. |
Abstract
N , N ‐dimethyltryptamine (DMT) is a widely distributed plant alkaloid that displays partial agonist activity at the 5‐HT 2A receptor and induces intense psychedelic effects in humans when administered parenterally. However, self‐administration studies have reported a total lack of activity following oral intake. This is thought to be due to extensive degradation by monoamine oxidase (MAO). Despite increased use of DMT and DMT‐containing preparations, such as the plant tea ayahuasca, the biotransformation of DMT in humans when administered alone is relatively unknown. Here we used high performance liquid chromatography (HPLC)/electrospray ionization (ESI)/selected reaction monitoring (SRM)/tandem mass spectrometry (MS/MS) to characterize the metabolism and disposition of oral and smoked DMT. Twenty‐four‐hour urine samples were obtained from 6 DMT users before and after intake of 25 mg DMT doses on two separate sessions. In one session, DMT was taken orally and in another it was smoked. After oral ingestion, no psychotropic effects were experienced and no DMT was recovered in urine. MAO‐dependent indole‐3‐acetic acid (IAA) represented 97% of the recovered compounds, whereas DMT‐ N ‐oxide (DMT‐NO) accounted for only 3%. When the smoked route was used, the drug was fully psychoactive, unmetabolized DMT and DMT‐NO rose to 10% and 28%, respectively, and IAA levels dropped to 63%. An inverse correlation was found between the IAA/DMT‐NO ratio and subjective effects scores. These findings show that in the smoked route a shift from the highly efficient MAO‐dependent to the less efficient CYP‐dependent metabolism takes place. This shift leads to psychoactivity and is analogous to that observed in ayahuasca preparations combining DMT with MAO inhibitors. Copyright © 2014 John Wiley & Sons, Ltd.
Comparable studies
Other observational and cohort studies on DMT, most cited first.
Citations in the library
Cited by 85
- Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression Journal of Clinical Psychopharmacology December 11, 2015
- Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years Therapeutic Advances in Psychopharmacology March 18, 2016
- The hallucinogenic world of tryptamines: an updated review. Archives of Toxicology August 1, 2015
- Designer drugs: mechanism of action and adverse effects Archives of Toxicology April 1, 2020
- Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews Expert Review of Clinical Pharmacology August 13, 2018
and 80 more in the library
Cites 17
- Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Psychopharmacology July 7, 2006
- Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects. Psychopharmacology December 1, 2011
- Dose-Response Study of N,N-Dimethyltryptamine in Humans Archives of General Psychiatry February 1, 1994
- Monoamine oxidase inhibitors in South American hallucinogenic plants: Tryptamine and β-carboline constituents of Ayahuasca Journal of Ethnopharmacology April 1, 1984
- Human Pharmacology of Ayahuasca: Subjective and Cardiovascular Effects, Monoamine Metabolite Excretion, and Pharmacokinetics Journal of Pharmacology and Experimental Therapeutics June 18, 2003
and 12 more in the library